{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:05:56Z","timestamp":1790197556928,"version":"4.1.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Intravenous iron is commonly withheld during acute infection due to concerns that iron availability may promote microbial growth and worsen outcomes. Yet, the supporting clinical evidence is less definitive than one might realise. Early clinical concern was derived largely from observational studies in haemodialysis populations where intravenous iron exposure, particularly at higher or bolus dosing, was associated with bacteraemia or infection-related hospitalisation. However, these studies were susceptible to confounding and not uniformly replicated. More recent evidence is mixed. A large meta-analysis found a modest increase in infection risk with intravenous iron but also showed improved haemoglobin and reduced transfusion requirements. Newer cohort studies in acutely infected patients suggest intravenous iron is not uniformly followed by deterioration and may, in selected groups, be associated with improved haemoglobin recovery and survival. We argue that blanket avoidance is overgeneralised. Intravenous iron has a role to play in acute infection in selected populations and future research will help inform a more nuanced approach.<\/jats:p>","DOI":"10.1093\/qjmed\/hcag113","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:53:32Z","timestamp":1776430412000},"page":"587-589","source":"Crossref","is-referenced-by-count":0,"title":["Should we reconsider withholding iron replacement therapy in acute infection?"],"prefix":"10.1093","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0808-8779","authenticated-orcid":false,"given":"Gerard","family":"Gurumurthy","sequence":"first","affiliation":[{"name":"Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust , Cambridge,","place":["UK"]},{"name":"The Queen Elizabeth Hospital Kings Lynn NHS Foundation Trust , Kings Lynn,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Groves","sequence":"additional","affiliation":[{"name":"The Queen Elizabeth Hospital Kings Lynn NHS Foundation Trust , Kings Lynn,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith","family":"Bayan","sequence":"additional","affiliation":[{"name":"The Queen Elizabeth Hospital Kings Lynn NHS Foundation Trust , Kings Lynn,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"2026092316322630100_hcag113-B1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12882-025-04115-1","article-title":"UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease","volume":"26","author":"Bhandari","year":"2025","journal-title":"BMC Nephrol"},{"key":"2026092316322630100_hcag113-B2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2025.06.006","article-title":"KDIGO 2026 clinical practice guideline for the management of anemia in chronic kidney disease (CKD)","volume":"109","author":"Tonelli","year":"2026","journal-title":"Kidney Int"},{"key":"2026092316322630100_hcag113-B3","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1128\/IAI.00602-13","article-title":"Sequestration and scavenging of iron in infection","volume":"81","author":"Parrow","year":"2013","journal-title":"Infect Immun"},{"key":"2026092316322630100_hcag113-B4","first-page":"768","article-title":"Hepcidin and the iron-infection axis","volume":"338","author":"Drakesmith","year":"2012","journal-title":"Science (1979)"},{"key":"2026092316322630100_hcag113-B5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1755.2003.00125.x","article-title":"High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity","volume":"64","author":"Deicher","year":"2003","journal-title":"Kidney Int"},{"key":"2026092316322630100_hcag113-B6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1525-1594.2001.06894.x","article-title":"Risk of bacterial infection in patients under intravenous iron therapy: dose versus length of treatment","volume":"25","author":"Canziani","year":"2001","journal-title":"Artif Organs"},{"key":"2026092316322630100_hcag113-B7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1086\/382878","article-title":"Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy","volume":"38","author":"Teehan","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2026092316322630100_hcag113-B8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5414\/CNP66348","article-title":"Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients","volume":"66","author":"Sirken","year":"2006","journal-title":"Clin Nephrol"},{"key":"2026092316322630100_hcag113-B9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5414\/CNP57457","article-title":"Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients","volume":"57","author":"Hoen","year":"2002","journal-title":"Clin Nephrol"},{"key":"2026092316322630100_hcag113-B10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2012121164","article-title":"Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients","volume":"24","author":"Brookhart","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026092316322630100_hcag113-B11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2369-15-154","article-title":"Comparative short-term safety of bolus versus maintenance iron dosing in hemodialysis patients: a replication study","volume":"15","author":"Freburger","year":"2014","journal-title":"BMC Nephrol"},{"key":"2026092316322630100_hcag113-B12","doi-asserted-by":"crossref","first-page":"e2133935","DOI":"10.1001\/jamanetworkopen.2021.33935","article-title":"Risk of infection associated with administration of intravenous iron: a systematic review and meta-analysis","volume":"4","author":"Shah","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026092316322630100_hcag113-B13","article-title":"Intravenous iron in patients hospitalized with bacterial infections: utilization and outcomes","volume":"6","author":"Centanni","year":"2024","journal-title":"J Maine Med Cent"},{"key":"2026092316322630100_hcag113-B14","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/phar.4608","article-title":"Influence of intravenous iron on bacterial infection risk immediately following kidney transplantation","volume":"44","author":"January","year":"2024","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"2026092316322630100_hcag113-B15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1681\/ASN.2019090972","article-title":"Intravenous iron dosing and infection risk in patients on hemodialysis: a prespecified secondary analysis of the PIVOTAL trial","volume":"31","author":"Macdougall","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026092316322630100_hcag113-B16","first-page":"2025031965","article-title":"A retrospective, real-world study of IV iron use to treat iron deficiency anemia during acute infection","author":"Sohail","year":"2026","journal-title":"Blood"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcag113\/68133652\/hcag113.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/8\/587\/68133652\/hcag113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/8\/587\/68133652\/hcag113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:32:42Z","timestamp":1790195562000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/119\/8\/587\/8660661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4,21]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcag113","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,4,21]]}}}